title: Drug research: marketing before evidence, sales before safety.
authors.forename: David
authors.initials: D
authors.lastname: Klemperer
mesh_terms: D014150:Antipsychotic Agents / Q000191:economics / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000191:economics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000191:economics* / Q000941:ethics*; D016265:Conflict of Interest / Q000191:economics*; D004345:Drug Industry / Q000191:economics / Q000941:ethics*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000191:economics; D004994:Ethics, Pharmacy; D019317:Evidence-Based Medicine / Q000191:economics / Q000941:ethics; D005607:Fraud / Q000191:economics / Q000941:ethics; D005858:Germany; D006801:Humans; D033181:Information Dissemination; D040541:Marketing / Q000941:ethics*; D000077152:Olanzapine; D017594:Publication Bias; D012109:Research Support as Topic / Q000191:economics* / Q000941:ethics*; D018967:Risperidone / Q000191:economics / Q000627:therapeutic use*
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D018967:Risperidone; D000077152:Olanzapine
references.citation: JAMA. 2003 Jan 22-29;289(4):454-65
references.pmid: 12533125
references.citation: Am J Psychiatry. 2006 Feb;163(2):185-94
references.pmid: 16449469
references.citation: Dtsch Arztebl Int. 2010 Apr;107(16):279-85
references.pmid: 20467553
references.citation: JAMA. 2010 Mar 24;303(12):1194-5
references.pmid: 20332408
references.citation: JAMA. 2008 Apr 16;299(15):1813-7
references.pmid: 18413875
references.citation: Ann Fam Med. 2009 Nov-Dec;7(6):542-6
references.pmid: 19901314
references.citation: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Apr;52(4):463-8
references.pmid: 19308331
references.citation: N Engl J Med. 2004 Oct 21;351(17):1707-9
references.pmid: 15470193